Iran Antibiotic Manufacturing Company (BIUTIK) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- BIUTIK
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 10,376,317 | 8,742,983 | 7,223,752 | 3,589,193 | 1,914,580 | 1,447,578 |
| Cost of operating revenue | -5,404,477 | -5,348,115 | -4,919,510 | -2,956,652 | -1,335,008 | -951,651 |
| Gross profit (loss) | 4,971,840 | 3,394,868 | 2,304,242 | 632,541 | 579,572 | 495,927 |
| Selling, general and administrative expenses | -109,563 | -91,703 | -51,818 | -34,569 | -22,662 | -21,544 |
| Other income | 54,437 | 4,085 | 9,482 | 401 | 2,255 | 4,551 |
| Other expenses | -47,787 | 0 | 0 | -105,353 | -51,879 | 0 |
| Operating profit (loss) | 4,868,927 | 3,307,250 | 2,261,906 | 493,020 | 507,286 | 478,934 |
| Finance costs | -741,008 | -444,482 | -388,283 | -162,826 | -47,206 | -50,060 |
| Other non-operating income and expenses | 82,045 | 1,233 | 8,228 | 30,582 | 10,221 | 6,442 |
| Profit (loss) from continuing operations before tax | 4,209,964 | 2,864,001 | 1,881,851 | 360,776 | 470,301 | 435,316 |
| Current year tax | -999,861 | -1,422,435 | -118,214 | -46,406 | -50,944 | -47,232 |
| Net profit (loss) from continuing operations | 3,210,103 | 1,441,566 | 1,763,637 | 314,370 | 419,357 | 388,084 |
| Net profit (loss) | 3,210,103 | 1,441,566 | 1,763,637 | 314,370 | 419,357 | 388,084 |
| Basic earnings (loss) per share | 4,007 rials | 1,799 rials | 2,196 rials | 392 rials | 597 rials | 552 rials |
| Net earnings (loss) per share, rials | 3,999 rials | 1,796 rials | 2,197 rials | 392 rials | 597 rials | 553 rials |
| Capital | 802,900 | 802,900 | 802,900 | 802,900 | 702,900 | 702,900 |
Reporting periods
37 periods are on file for this report, from the period ending 1395/12/30 to the period ending 1405/06/31.